Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James S Ware

Showing results (51-60 of 201) with videos related to

Pageof 21
Sort By:
Nature Communications|May 19, 2026
Gene-gene interactions between a LMNA variant and common polymorphisms drive early-onset atrial fibrillationAsia Owais, Hanna Chen, Hammad Farooq, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 19, 2024
Association between coronary microvascular dysfunction and exercise capacity in dilated cardiomyopathyAbhishek Dattani, Benjamin A Marrow, Gaurav S Gulsin, et al.
Clinical Science (London, England : 1979)|November 26, 2013
Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome)Mark Glover, James S Ware, Amanda Henry, et al.
NPJ Digital Medicine|December 5, 2025
The cost of explainability in artificial intelligence-enhanced electrocardiogram modelsKonstantinos Patlatzoglou, Libor Pastika, Joseph Barker, et al.
JAMA Cardiology|August 20, 2025
Artificial Intelligence-Enhanced Electrocardiography for Complete Heart Block Risk StratificationArunashis Sau, Henry Zhang, Joseph Barker, et al.
Journal of Molecular Biology|March 28, 2026
Gene2Phenotype: a database of structured human monogenic diseases and pathomechanismsSarah E Hunt, Diana Lemos, Seeta Ramaraju Pericherla, et al.
The Lancet. Digital Health|February 27, 2025
Artificial intelligence-enhanced electrocardiography for the identification of a sex-related cardiovascular risk continuum: a retrospective cohort studyArunashis Sau, Ewa Sieliwonczyk, Konstantinos Patlatzoglou, et al.
Circulation. Genomic and Precision Medicine|September 5, 2020
Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic CardiomyopathyAkl C Fahed, Georges Nemer, Fadi F Bitar, et al.
Nature Genetics|January 26, 2021
Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivityAndrew R Harper, Anuj Goel, Christopher Grace, et al.
American Journal of Human Genetics|March 15, 2025
Actionable genetic variants in 4,198 Scottish participants from the Orkney and Shetland founder populations and implementation of return of resultsShona M Kerr, Lucija Klaric, Marisa D Muckian, et al.
Pageof 21

Showing results (51-60 of 201) with videos related to

Sort By:
Pageof 21
Nature Communications|May 19, 2026
Gene-gene interactions between a LMNA variant and common polymorphisms drive early-onset atrial fibrillationAsia Owais, Hanna Chen, Hammad Farooq, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 19, 2024
Association between coronary microvascular dysfunction and exercise capacity in dilated cardiomyopathyAbhishek Dattani, Benjamin A Marrow, Gaurav S Gulsin, et al.
Clinical Science (London, England : 1979)|November 26, 2013
Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome)Mark Glover, James S Ware, Amanda Henry, et al.
NPJ Digital Medicine|December 5, 2025
The cost of explainability in artificial intelligence-enhanced electrocardiogram modelsKonstantinos Patlatzoglou, Libor Pastika, Joseph Barker, et al.
JAMA Cardiology|August 20, 2025
Artificial Intelligence-Enhanced Electrocardiography for Complete Heart Block Risk StratificationArunashis Sau, Henry Zhang, Joseph Barker, et al.
Journal of Molecular Biology|March 28, 2026
Gene2Phenotype: a database of structured human monogenic diseases and pathomechanismsSarah E Hunt, Diana Lemos, Seeta Ramaraju Pericherla, et al.
The Lancet. Digital Health|February 27, 2025
Artificial intelligence-enhanced electrocardiography for the identification of a sex-related cardiovascular risk continuum: a retrospective cohort studyArunashis Sau, Ewa Sieliwonczyk, Konstantinos Patlatzoglou, et al.
Circulation. Genomic and Precision Medicine|September 5, 2020
Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic CardiomyopathyAkl C Fahed, Georges Nemer, Fadi F Bitar, et al.
Nature Genetics|January 26, 2021
Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivityAndrew R Harper, Anuj Goel, Christopher Grace, et al.
American Journal of Human Genetics|March 15, 2025
Actionable genetic variants in 4,198 Scottish participants from the Orkney and Shetland founder populations and implementation of return of resultsShona M Kerr, Lucija Klaric, Marisa D Muckian, et al.
Pageof 21